MedTrace Logo

Safety and Efficacy of Palonosetron in Preventing Chemotherapy-induced Nausea and Vomiting

NCT00503386 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 144

Last updated 2010-09-17

No results posted yet for this study

Summary

The purpose of this study is to determine whether palonosetron is tolerate and effective in preventing chemotherapy-induced nausea and vomiting in oriental population. The study is comparing the safety and efficacy of palonosetron with granisetron, a frequently used antiemetic in China.

Conditions

Interventions

DRUG

Palonosetron

DRUG

Granisetron

Sponsors & Collaborators

  • Sun Yat-sen University

    collaborator OTHER

  • Tigermed Consulting Co., Ltd

    collaborator INDUSTRY

  • Hangzhou Jiuyuan Gene Engineering Co. Ltd.,

    lead INDUSTRY

Principal Investigators

  • Tongyu Lin, M.D. · Sun Yat-sen University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2006-10-31
Completion
2006-10-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00503386 on ClinicalTrials.gov